Literature DB >> 9803826

Multiple P2 receptor subtypes on platelets: a new interpretation of their function.

S P Kunapuli1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9803826     DOI： 10.1016/s0165-6147(98)01248-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  17 in total

1.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor.

Authors:  Anna-Karin Wihlborg; Malin Malmsjö; Atli Eyjolfsson; Ronny Gustafsson; Kenneth Jacobson; David Erlinge
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

3.  P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.

Authors:  S F Maloney; Lawrence F Brass; S L Diamond
Journal:  Integr Biol (Camb)       Date:  2010-01-05       Impact factor: 2.192

Review 4.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 5.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

6.  Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.

Authors:  J Simon; P Vigne; K M Eklund; A D Michel; A M Carruthers; P P Humphrey; C Frelin; E A Barnard
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.

Authors:  A Sugidachi; F Asai; K Yoneda; R Iwamura; T Ogawa; K Otsuguro; H Koike
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

8.  Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.

Authors:  P Sabala; R Czajkowski; K Przybyłek; K Kalita; L Kaczmarek; J Barańska
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

9.  The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.

Authors:  A Sugidachi; F Asai; T Ogawa; T Inoue; H Koike
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 10.  Current developments in anti-platelet therapy.

Authors:  Florian B Mayr; Bernd Jilma
Journal:  Wien Med Wochenschr       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.